William Backus Biography and Net Worth

CAO of Balchem


Presently, William A. Backus holds the position of Chief Accounting Officer & Treasurer at Balchem Corp.

In his past career Mr. Backus occupied the position of Controller of Stewart EFI LLC.

What is William A. Backus' net worth?

The estimated net worth of William A. Backus is at least $851,142.88 as of February 26th, 2024. Mr. Backus owns 5,914 shares of Balchem stock worth more than $851,143 as of April 18th. This net worth approximation does not reflect any other assets that Mr. Backus may own. Additionally, Mr. Backus receives a salary of $560,790.00 as CAO at Balchem. Learn More about William A. Backus' net worth.

How old is William A. Backus?

Mr. Backus is currently 58 years old. There are 9 older executives and no younger executives at Balchem. The oldest executive at Balchem is Mr. Michael R. Sestrick Ph.D., Senior VP & CTO, who is 60 years old. Learn More on William A. Backus' age.

What is William A. Backus' salary?

As the CAO of Balchem Co., Mr. Backus earns $560,790.00 per year. There are 5 executives that earn more than Mr. Backus. The highest earning executive at Balchem is Mr. Theodore L. Harris, Chairman, CEO & President, who commands a salary of $2,330,000.00 per year. Learn More on William A. Backus' salary.

How do I contact William A. Backus?

The corporate mailing address for Mr. Backus and other Balchem executives is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. Balchem can also be reached via phone at (845) 326-5600 and via email at [email protected]. Learn More on William A. Backus' contact information.

Has William A. Backus been buying or selling shares of Balchem?

William A. Backus has not been actively trading shares of Balchem over the course of the past ninety days. Most recently, William A. Backus sold 7,000 shares of the business's stock in a transaction on Monday, February 26th. The shares were sold at an average price of $155.19, for a transaction totalling $1,086,330.00. Following the completion of the sale, the chief accounting officer now directly owns 5,914 shares of the company's stock, valued at $917,793.66. Learn More on William A. Backus' trading history.

Who are Balchem's active insiders?

Balchem's insider roster includes William Backus (CAO), David Fischer (Director), Scott Mason (VP), and Job van Gunsteren (VP). Learn More on Balchem's active insiders.

Are insiders buying or selling shares of Balchem?

During the last twelve months, insiders at the basic materials company sold shares 7 times. They sold a total of 82,730 shares worth more than $12,643,043.10. The most recent insider tranaction occured on February, 26th when CAO William A Backus sold 7,000 shares worth more than $1,086,330.00. Insiders at Balchem own 1.8% of the company. Learn More about insider trades at Balchem.

Information on this page was last updated on 2/26/2024.

William A. Backus Insider Trading History at Balchem

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2024Sell7,000$155.19$1,086,330.005,914View SEC Filing Icon  
2/23/2024Sell9,180$156.37$1,435,476.6012,914View SEC Filing Icon  
2/21/2024Sell15,000$154.73$2,320,950.0012,914View SEC Filing Icon  
8/9/2021Sell10,520$132.02$1,388,850.40View SEC Filing Icon  
8/6/2021Sell12,248$134.04$1,641,721.92View SEC Filing Icon  
3/13/2017Sell48,500$83.60$4,054,600.0021,775View SEC Filing Icon  
3/3/2017Sell14,000$86.88$1,216,320.0030,775View SEC Filing Icon  
8/26/2016Sell12,000$68.64$823,680.0029,308View SEC Filing Icon  
See Full Table

William A. Backus Buying and Selling Activity at Balchem

This chart shows William A Backus's buying and selling at Balchem by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Balchem Company Overview

Balchem logo
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Read More

Today's Range

Now: $143.12
Low: $142.65
High: $145.53

50 Day Range

MA: $152.43
Low: $140.58
High: $157.27

2 Week Range

Now: $143.12
Low: $110.74
High: $159.52

Volume

124,973 shs

Average Volume

105,138 shs

Market Capitalization

$4.62 billion

P/E Ratio

42.72

Dividend Yield

0.54%

Beta

0.71